156. Rett syndrome Clinical trials / Disease details

Clinical trials : 40 /  Drugs : 53 - (DrugBank : 19) / Drug target genes : 77 - Drug target pathways : 113

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01777542
(ClinicalTrials.gov)		January 201323/1/2013Treatment of Rett Syndrome With Recombinant Human IGF-1Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)Rett SyndromeDrug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Drug: PlaceboBoston Children's HospitalInternational Rett Syndrome FoundationCompleted2 Years10 YearsFemale30Phase 2United States
2NCT01253317
(ClinicalTrials.gov)		December 20102/12/2010Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With IGF-1Rett SyndromeDrug: rhIGF-1Boston Children’s HospitalInternational Rett Syndrome Foundation;Autism SpeaksCompleted2 Years12 YearsFemale12Phase 1United States